BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 7874757)

  • 1. [Gene diagnosis of pancreatic adenocarcinoma].
    Wang ZY; Liu TH; Cui QC
    Zhonghua Bing Li Xue Za Zhi; 1994 Oct; 23(5):270-3. PubMed ID: 7874757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of c-Ki-ras mutation by PCR/RFLP analysis and diagnosis of pancreatic adenocarcinomas.
    Urban T; Ricci S; Grange JD; Lacave R; Boudghene F; Breittmayer F; Languille O; Roland J; Bernaudin JF
    J Natl Cancer Inst; 1993 Dec; 85(24):2008-12. PubMed ID: 7902444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of c-Ki-ras gene codon 12 mutations from pancreatic duct brushings in the diagnosis of pancreatic tumours.
    Van Laethem JL; Vertongen P; Deviere J; Van Rampelbergh J; Rickaert F; Cremer M; Robberecht P
    Gut; 1995 May; 36(5):781-7. PubMed ID: 7797131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Point mutation at codon 12 of c-Ki-ras oncogene in human pancreatic neoplasms and normal human pancreas tissue].
    Cui Q; Wang Z; Chen J
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1994 Jun; 16(3):201-5. PubMed ID: 7805165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Frequency of K-ras mutation in biliary and pancreatic tumors].
    Roa JC; Anabalón L; Tapia O; Melo A; de Aretxabala X; Roa I
    Rev Med Chil; 2005 Dec; 133(12):1434-40. PubMed ID: 16446870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A two-step enriched-nested PCR technique enhances sensitivity for detection of codon 12 K-ras mutations in pancreatic adenocarcinoma.
    Banerjee SK; Makdisi WF; Weston AP; Campbell DR
    Pancreas; 1997 Jul; 15(1):16-24. PubMed ID: 9211488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Oncogene expression and point mutation in human pancreatic adenocarcinomas].
    Li DC; Liu TH
    Zhonghua Bing Li Xue Za Zhi; 1992 Jun; 21(3):152-5. PubMed ID: 1477938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis of pancreatic adenocarcinoma by polymerase chain reaction from pancreatic secretions.
    Trümper LH; Bürger B; von Bonin F; Hintze A; von Blohn G; Pfreundschuh M; Daus H
    Br J Cancer; 1994 Aug; 70(2):278-84. PubMed ID: 8054276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization.
    Hruban RH; van Mansfeld AD; Offerhaus GJ; van Weering DH; Allison DC; Goodman SN; Kensler TW; Bose KK; Cameron JL; Bos JL
    Am J Pathol; 1993 Aug; 143(2):545-54. PubMed ID: 8342602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of hepatic micrometastasis in pancreatic adenocarcinoma patients by two-stage polymerase chain reaction/restriction fragment length polymorphism analysis.
    Inoue S; Nakao A; Kasai Y; Harada A; Nonami T; Takagi H
    Jpn J Cancer Res; 1995 Jul; 86(7):626-30. PubMed ID: 7559078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Ki-ras mutation as a molecular tumor marker for carcinoma of the pancreas].
    Daus H; Trümper L; Bürger B; Jacobs G; Kriener S; von Blohn G; Zeitz M; Pfreundschuh M
    Dtsch Med Wochenschr; 1995 Jun; 120(23):821-5. PubMed ID: 7781522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical application of ras gene mutation for diagnosis of pancreatic adenocarcinoma.
    Tada M; Omata M; Ohto M
    Gastroenterology; 1991 Jan; 100(1):233-8. PubMed ID: 1983826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kras mutation analysis of fine needle aspirate under EUS guidance facilitates risk stratification of patients with pancreatic mass.
    Maluf-Filho F; Kumar A; Gerhardt R; Kubrusly M; Sakai P; Hondo F; Matuguma SE; Artifon E; Monteiro da Cunha JE; César Machado MC; Ishioka S; Forero E
    J Clin Gastroenterol; 2007; 41(10):906-10. PubMed ID: 18090159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Detection of point mutations on the Ki-ras gene using the PCR technique].
    Janda J; Krechler T; Dufek V; Klener P
    Cesk Patol; 1998 Jan; 34(1):33-7. PubMed ID: 9560882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The utility of Ki-ras mutation analysis in the cytologic diagnosis of pancreatobiliary neoplasma.
    Dillon DA; Johnson CC; Topazian MD; Tallini G; Rimm DL; Costa JC
    Cancer J; 2000; 6(5):294-301. PubMed ID: 11079168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of K-ras mutations in the stool of patients with pancreatic adenocarcinoma and pancreatic ductal hyperplasia.
    Caldas C; Hahn SA; Hruban RH; Redston MS; Yeo CJ; Kern SE
    Cancer Res; 1994 Jul; 54(13):3568-73. PubMed ID: 8012983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of c-Ki-ras point mutation from pancreatic juice. A useful diagnostic approach for pancreatic carcinoma.
    Miki H; Matsumoto S; Harada H; Mori S; Haba R; Ochi K; Kobayashi S; Ohmori M
    Int J Pancreatol; 1993 Oct; 14(2):145-8. PubMed ID: 8283078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Detection of c-Ki-ras oncogene codon 12 point mutations in lung carcinoma, gastric carcinoma and hepatic carcinoma].
    Cui Q; Wang Z; Chen J; Liu T
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1996 Apr; 18(2):95-8. PubMed ID: 9208596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenocarcinoma of the pancreas: detection of occult metastases in regional lymph nodes by a polymerase chain reaction-based assay.
    Demeure MJ; Doffek KM; Komorowski RA; Wilson SD
    Cancer; 1998 Oct; 83(7):1328-34. PubMed ID: 9762933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [K-ras gene mutation in gallbladder carcinoma].
    Roa JC; Roa I; de Aretxabala X; Melo A; Faría G; Tapia O
    Rev Med Chil; 2004 Aug; 132(8):955-60. PubMed ID: 15478297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.